Animal models for atopic dermatitis: Are they relevant to human disease?

Journal of Dermatological Science

Volumn 36, Issue 1, 2004, Pages 1-9

  Shiohara, Tetsuo ^a   Hayakawa, Jun ^a   Mizukawa, Yoshiko ^a  

^a KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Atopic dermatitis; Corticosteroids; Hapten; IL 18; NC Nga mice; RelB; Tacrolimus; Th1 and Th2 cytokines

Indexed keywords

CD40 LIGAND; CORTICOSTEROID; CX 659S; CYTOKINE; GAMMA INTERFERON; HAPTEN; IMMUNOGLOBULIN E; INTERLEUKIN 18; INTERLEUKIN 4; OVALBUMIN; OXAZOLONE; PICRYL CHLORIDE; TACROLIMUS; UNCLASSIFIED DRUG; URACIL DERIVATIVE;

ATOPIC DERMATITIS; CELL INFILTRATION; CLINICAL TRIAL; DISEASE SEVERITY; ECZEMA; EOSINOPHIL; GENETIC HETEROGENEITY; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HYPERSENSITIVITY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGLOBULIN PRODUCTION; IMMUNOHISTOCHEMISTRY; INTERFERON PRODUCTION; KNOCKOUT MOUSE; MACROPHAGE; MOUSE STRAIN; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; SENSITIVITY ANALYSIS; SKIN INFLAMMATION; T LYMPHOCYTE; TRANSGENIC MOUSE; X IRRADIATION;

ANIMALS; DERMATITIS, ATOPIC; DISEASE MODELS, ANIMAL; HAPTENS; HUMANS; INFLAMMATION; INTERLEUKIN-18; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MODELS, BIOLOGICAL; PICRYL CHLORIDE;

EID: 5644282657     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2004.02.013     Document Type: Review

References (38)

1. Schultz-Larsen F., Hanifin J.M. Epidemiology of atopic dermatitis. Immunol. Allergy Clin. North Am. 22:2002;1-24
2. Leung D.Y. Atopic dermatitis. Lancet. 361:2003;151-160
3. Mckeever T.M., Lewis S.A., Smith C., Collins J., Heatlie H., Frisher M., et al. Early exposure to infections and antibiotics and the incidence of allergic disease: a birth cohort study with the west Midlands General Practice Research Database. J. Allergy Clin. Immunol. 109:2002;43-50
4. Charman C.R., Morris A.D., Williams H.C. Topical corticosteroid phobia in patients with atopic eczema. Br. J. Dermatol. 142:2000;931-936
5. Matsuda H., Watanabe N., Geba G.P., Sperl J., Tsudzuki M., Hiroi J., et al. Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int. Immunol. 9:1997;461-466
6. Kitagaki H., Fujisawa S., Watanabe K., Hayakawa K., Shiohara T. Immediate-type hypersensitivity response followed by a late reaction is induced by repeated epicutaneous application of contact sensitizing agents in mice. J. Invest. Dermatol. 105:1995;749-755
7. Konishi H., Tsutsui H., Murakami T., Yumikura-Futatsugi S., Yamanaka K., Tanaka M., et al. IL-18 contributes to the spontaneous development of atopic dermatitis-like inflammatory skin lesion independently of IgE/stat6 under specific pathogen-free conditions. Proc. Natl. Acad. Sci. U.S.A. 99:2002;11340-11345
8. Kawase Y., Hoshino T., Yokota K., Kuzuhara A., Kirii Y., Nishiwaki E., et al. Exacerbated and prolonged allergic and non-allergic inflammatory cutaneous reaction in mice with targeted interleukin-18 expression in the skin. J. Invest. Dermatol. 121:2003;502-509
9. Barton D., HogenEsch J., Weih F. Mice lacking the transcription factor REIB develop T cell-dependent skin lesions similar to human atopic dermatitis. Eur. J. Immuol. 30:2000;2323-2332
10. Chan L.S., Robinson N., Xu L. Expression of interleukin 4 in the epidermis of transgenic mice results in a pruritic inflammatory skin disease: an experimental animal model to study atopic dermatitis. J. Invest. Dermatol. 117:2001;977-983
11. Kondo K, Nagami T, Tadokoro S. Differences in haematopoeitic death among inbred strains of mice. In: Bond P, Sugawara S, editors. Comparative cellular and species radiosensitivity. Tokyo, Japan: Igakushoin; 1969. p. 20.
12. Matsumoto M., Ra C., Kawamoto K., Sato H., Itakura A., Sawada J., et al. IgE hyperproduction though enhanced tyrosine phosphorylation of Janus Kinase 3 in NC/Nga mice, a model for human atopic dermatitis. J. Immunol. 162:1999;1056-1063
13. Matsumoto M., Itakura A., Tanaka A., Fujiwara C., Matsuda H. Inability of IL-12 to down-regulate IgE synthesis due to defective production of IFN-γ in atopic NC/Nga mice. J. Immunol. 167:2001;5955-5962
14. Vestergaard C., Yoneyama H., Murai M., Nakamura K., Tamaki K., Terashima Y., et al. Overproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions. J. Clin. Invest. 104:1999;1097-1105
15. Aioi A., Tonogaito H., Suto H., Hamad K., Ra C., Ogawa H., et al. Impairment of skin barrier function in NC/Nga mice as a possible murine model for atopic dermatitis. Br. J. Dermatol. 144:2001;12-18
16. Yagi R., Nagai H., Iigo Y., Akimoto T., Arai T., Kubo M. Development of atopic dermatitis-like skin lesions in STAT6-deficient NC/Nga mice. J. Immunol. 168:2002;2020-2027
17. Kohara Y., Tanabe K., Matsuoka K., Kanda N., Matsuda H., Karasuyama H., et al. A major determinant quantitative-trait locus responsible for atopic dermatitis-like lesions in NC/Nga mice is located on Chromosome 9. Immunogenetics. 53:2001;15-21
18. Daniels S.E., Bhattacharrya S., James A., Leaves N.I., Young A., Hill M.R., et al. A genome-wide search for quantitative trait loci underlying asthma. Nature. 383:1996;247-250
19. Sasagawa T., Higashi Y., Sakuma S., Hirayama Y., Sasagawa Y., Ohkubo Y., et al. Atopic dermatitis-like skin lesions induced by topical application of mite antigens in NC/Nga mice. Int. Arch. Allergy Immunol. 126:2001;239-247
20. Hiroi J., Sengoku T., Morita K., Kishi S., Sato S., Ogawa T., et al. Effect of tacrolimus hydrate (FK506) ointment on spontaneous dermatitis in NC/Nga mice. Jpn. J. Pharmacol. 76:1998;175-183
21. Thomas W.R., Watkins M.C., Jouhal S.S., Asherson G.L. Induction and modification of anti-TNP reaginic and IgG antibody response by reactive trinitrophenyl derivatives. Immunology. 35:1978;673-682
22. Kitagaki H., Ono N., Hayakawa K., Kitazawa T., Watanabe K., Shiohara T. Repeated elicitation of contact hypersensitivity induces a shift in cutaneous cytokine milieu from a T helper cell type 1 to a T helper cell type 2 profile. J. Immunol. 159:1997;2484-2491
23. Leung D.Y.M. Atopic dermatitis: new insights and opportunities for therapeutic intervention. J. Allergy Clin. Immunol. 105:2000;860-876
24. Akdis C.A., Akdis M., Trautmann A., Blaser K. Immune regulation in atopic dermatitis. Curr. Opin. Immunol. 12:2000;641-646
25. Johansson S.G., Hourihane J.O., Bouswuet J., Bruijnzeel-Koomen C., Dreborg S., Haahtela T., et al. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy. 56:2001;813-824
26. Inoue Y., Isobe M., Shiohara T., Goto Y., Hayashi H. Protective and curative effects of topically applied CX-659S a novel diaminouracil derivative, on chronic picryl chloride-induced contact hypersensitivity responses. Br. J. Dermatol. 147:2002;675-682
27. Inoue Y., Isobe M., Shiohara T., Hayashi H. Inhibitory activity of CX-659S, a novel diaminouracil derivative, against the rebound phenomenon following withdrawal of corticosteroid therapy for chronic contact hypersensitivity responses. Int. Arch. Allergy Immunol. 131:2003;143-152
28. Boguniewicz M., Fiedler V.C., Raimer S., Lawrence I.D., Leung D.Y., Hanifin J.M. A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children. J. Allergy Clin. Immunol. 102:1998;637-644
29. Hanifin J.M., Ling M.R., Langley R., Breneman D., Rafal E. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients. Part 2. Efficacy. J. Am. Acad. Dermatol. 44:2001;S28-38
30. Spergel J.M., Mizoguchi E., Oettgen H., Bhan A.K., Geha R.S. Roles of Th1 and Th2 cytokines in a murine model of allergic dermatitis. J. Clin. Invest. 103:1999;1103-1111
31. Ahn H.J., Maruo S., Tomura M., Mu J., Hamaoka T., Nakanishi K., et al. A mechanism underlying synergy between IL-12 and IFN-γ-inducing factor in enhanced production of IFN-γ J. Immunol. 159:1997;2125-2131
32. Robinson D., Shibuya K., Mui A., Zonin F., Murphy E., Sana T., et al. IGIF does not drive Th1 development but synergizes with IL-12 for interferon-γ production and activates IRAK and NFκB. Immunity. 7:1997;571-581
33. + T cells. Eur. J. Immunol. 30:2000;1998-2006
34. Xu D., Trajkovic V., Hunter D., Leung B.P., Schultz K., Gracie J.A., et al. IL-18 induces the differentiation of Th1 or Th2 cells depending upon cytokine milieu and genetic background. Eur. J. Immunol. 30:2000;3147-3156
35. Hoshino T., Kawase Y., Okamoto M., Yokota K., Yoshino K., Yamanura K., et al. IL-18-transgenic mice: in vivo evidence of a broad role for IL-18 in modulating immune function. J. Immunol. 166:2001;7014-7018
36. Tanaka T., Tsutsui H., Yoshimoto T., Kotani M., Matsumoto M., Fujita A., et al. Interleukin-18 is elevated in the sera from patients with atopic dermatitis and from atopic dermatitis model mice, NC/Nga. Int. Arch. Allergy Immunol. 125:2001;236-240
37. Higa S., Kotani M., Matsumoto M., Fujita A., Hirano T., Suemura M., et al. Administration of anti-interleukin 18 antibody fails to inhibit development of dermatitis in atopic dermatitis-model mice. Br. J. Dermatol. 149:2003;39-45
38. Barton D., HogenEsch H., Weih F. Mice lacking the transcription factor ReIB develop T cell-dependent skin lesions similar to human atopic dermatitis. Eur. J. Immunol. 30:2000;2323-2332